Thromboprophylaxis and clinical outcomes in moderate COVID-19 patients: A comparative study
Research article
[키워드] Anticoagulant
Anticoagulants
bleeding
Care
Clinical outcome
clinical outcomes
complications
coronavirus disease
COVID-19
discharge
dose
Efficacy
enoxaparin
evaluated
hospital
Hospital stay
Hospitalization
hypoxia
ICU
ICU admission
in-hospital mortality
incidence
intensive care
involved
medication
Mild
moderate
Moderate COVID-19
mortality rate
objective
outcome
Patient
patients with moderate
Pneumonia
Prophylactic
Prophylaxis
proportion
Result
rivaroxaban
significant difference
subcutaneously
Thromboprophylaxis
thrombotic
thrombotic complication
Thrombotic events
transferred
Treatment
two groups
[DOI] 10.1016/j.sapharm.2022.07.004 [Article Type] Research article
[DOI] 10.1016/j.sapharm.2022.07.004 [Article Type] Research article